Contact this trialFirst, we need to learn more about you.
Cancer Imaging Agent
Copper Cu 64 PSMA I&T for Prostate Adenocarcinoma
Recruiting2 awardsPhase 3
Omaha, Nebraska
This trial will test a new imaging technique using copper Cu 64 PSMA I&T injection in patients with newly diagnosed aggressive prostate cancer to see if it can help doctors better visualize the extent of the cancer
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.